Idexx Laboratories Inc (IDXX)

Sector: Healthcare
Industry: In Vitro & In Vivo Diagnostic Substances
Country: United States
Exchange: NASDAQ
Market cap: $39.90B

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Latest financial period: June 30, 2026
Filed with the SEC: August 4, 2026
Estimated earnings date: November 2, 2026

Menu

Home

Compare

Next Earnings Reports

How this site works

Terms of use

About